Skip to main content
. 2020 Mar 25;22(9):1675–1683. doi: 10.1002/ejhf.1787

Table 4.

Association of changes in high‐sensitivity C‐reactive protein and serum uric acid with clinical outcomes

Direction of biomarker change from baseline to end of treatment n Patients with an event, n Event proportion, % Odds ratio 95% CI P‐value
hsCRP
Increase 142 31 21.8% 0.58 0.31–1.08 0.08
Decrease 186 26 14.0%
SUA
Increase 176 35 19.9% 0.70 0.38–1.27 0.26
Decrease 169 25 14.8%

CI, confidence interval; hsCRP, high‐sensitivity C‐reactive protein; SUA, serum uric acid.